CH659067A5 - Phenetanolamine und verwendung solcher verbindungen zur herstellung von pharmazeutischen mitteln. - Google Patents

Phenetanolamine und verwendung solcher verbindungen zur herstellung von pharmazeutischen mitteln. Download PDF

Info

Publication number
CH659067A5
CH659067A5 CH105984A CH105984A CH659067A5 CH 659067 A5 CH659067 A5 CH 659067A5 CH 105984 A CH105984 A CH 105984A CH 105984 A CH105984 A CH 105984A CH 659067 A5 CH659067 A5 CH 659067A5
Authority
CH
Switzerland
Prior art keywords
compound
formula
group
pharmaceutically acceptable
compounds
Prior art date
Application number
CH105984A
Other languages
German (de)
English (en)
Inventor
William T Comer
Xina Nair
Herbert R Roth
Davis L Jun Temple
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/575,418 external-priority patent/US4540581A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of CH659067A5 publication Critical patent/CH659067A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16Tryptamines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CH105984A 1983-03-04 1984-03-02 Phenetanolamine und verwendung solcher verbindungen zur herstellung von pharmazeutischen mitteln. CH659067A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47197683A 1983-03-04 1983-03-04
US06/575,418 US4540581A (en) 1984-01-31 1984-01-31 Topical nonsteroidal anti-inflammatory compositions and uses

Publications (1)

Publication Number Publication Date
CH659067A5 true CH659067A5 (de) 1986-12-31

Family

ID=27043623

Family Applications (1)

Application Number Title Priority Date Filing Date
CH105984A CH659067A5 (de) 1983-03-04 1984-03-02 Phenetanolamine und verwendung solcher verbindungen zur herstellung von pharmazeutischen mitteln.

Country Status (8)

Country Link
AU (1) AU570671B2 (da)
CA (1) CA1235662A (da)
CH (1) CH659067A5 (da)
DE (1) DE3407861A1 (da)
DK (1) DK140684A (da)
FR (1) FR2541999B1 (da)
GB (1) GB2135883B (da)
SE (1) SE460761B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8609331D0 (en) * 1986-04-16 1986-05-21 Pfizer Ltd Anti-arrythmia agents
EG18188A (en) * 1986-05-01 1992-09-30 Pfizer Ltd Process for preparation anti-arhythmia agents
HUT77308A (hu) * 1994-11-29 1998-03-30 Dainippon Pharmaceutical Co. Ltd. Indolszármazékok és e vegyületeket tartalmazó gyógyászati készítmények
FR2788770B1 (fr) * 1999-01-21 2001-02-16 Oreal Nouveaux 2-sulfonylaminophenols cationiques, leur utilisation a titre de coupleur pour la teinture d'oxydation, compositions les comprenant et procedes de teinture
CA2365503A1 (en) * 1999-04-01 2000-10-12 Koki Matsubara Method for the preparation of tricyclic amino alcohol derivatives through azides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB993584A (da) * 1962-01-24
GB1298771A (en) * 1969-04-01 1972-12-06 Sterling Drug Inc Carboxylic esters of hydroxyphenylalkanolamines
US4138581A (en) * 1969-04-01 1979-02-06 Sterling Drugs Inc. 3(Hydroxy or hydroxymethyl)-4(hydroxy)-α-(aminomethyl)benzyl alcohols
US3801631A (en) * 1972-02-16 1974-04-02 Mead Johnson & Co 2'-hydroxy-5'-(1-hydroxy-2-(2-methyl-1-phenyl-2-propylamino)ethyl)meth-anesulfonanilide and its salts
US3919424A (en) * 1972-02-16 1975-11-11 Mead Johnson & Co Bronchodilator process and composition
US3993776A (en) * 1973-10-15 1976-11-23 Mead Johnson & Company Anorexigenic process and composition
GB2077102A (en) * 1980-06-09 1981-12-16 Bristol Myers Co Ophthalmic compositions

Also Published As

Publication number Publication date
DE3407861A1 (de) 1984-09-06
CA1235662A (en) 1988-04-26
SE8401181L (sv) 1984-09-05
SE8401181D0 (sv) 1984-03-02
DK140684A (da) 1984-09-05
GB2135883B (en) 1987-10-21
GB8405487D0 (en) 1984-04-04
SE460761B (sv) 1989-11-20
FR2541999B1 (fr) 1986-09-19
AU2524084A (en) 1984-09-06
DK140684D0 (da) 1984-02-29
FR2541999A1 (fr) 1984-09-07
GB2135883A (en) 1984-09-12
AU570671B2 (en) 1988-03-24

Similar Documents

Publication Publication Date Title
DE60006280T2 (de) Beta 2 -adrenergische rezeptor-agonisten
DE1926045C3 (de) 2-Brom-oc-ergokryptin
DE1695556C3 (de) 3-Alkyl-1,2,3,4,4a,9-hexahydropyrazino[1,2-f]morphanthridinderivate
EP0207331B1 (de) Neue feste Formen von 2-Äthoxy-4-[N-(1-(2-piperidino-phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl]-benzoesäure, diese Formen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE1643224A1 (de) 1-Phenyl-2-aminoaethanolderivate und Verfahren zu ihrer Herstellung und ihre Verwendung
EP1203764B1 (de) Benzamidinderivate mit LTB4- antagonistischer Wirkung
DD235450B1 (de) Verfahren zur herstellung neuer 1-(2-hydroxyaryl)-alkan-1-on-oxime
DE2713389C2 (da)
CH638799A5 (de) 2h-benzofuran-3-on-derivate sowie ein verfahren zu deren herstellung und solche verbindungen enthaltende pharmazeutische praeparate.
DE3743265A1 (de) Neue ammoniumverbindungen, ihre herstellung und verwendung
DE2858766C2 (da)
EP0056956B1 (de) Neue Indanyl-Derivate, ihre Herstellung und Verwendung
CH659067A5 (de) Phenetanolamine und verwendung solcher verbindungen zur herstellung von pharmazeutischen mitteln.
DE3320394A1 (de) Optisch aktive n-arylierte oxazolidinon-(2)-derivate, deren verwendung als spezifische und reversible inhibitoren von monoaminooxydase des b-typs sowie verfahren zu deren herstellung
EP1483264B1 (de) 1-allyl-ergotalkaloid-derivate- verfahren zu ihrer herstellung und ihre verwendung zur prophylaxe und therapie von migräne
US4540581A (en) Topical nonsteroidal anti-inflammatory compositions and uses
DE2913295C2 (da)
DE60213450T2 (de) Chinolinderivate, herstellungsprozess und verwendung zur behandlung von krankheiten, bei den s-cd23 involviert ist
DD238793A5 (de) Verfahren zur herstellung von amin-derivaten des pyrazins
EP0377896A2 (de) Cyclooxygenase- und 5-Lipoxygenase-inhibierende Hydroxansäurederivate
US4574129A (en) Topical nonsteroidal anti-inflammatory methods
CA1235705A (en) Phenethanolamines and uses thereof
EP0008073A1 (de) Thiosubstituierte Diazacycloalkene, Verfahren zu ihrer Herstellung und pharmazeutische Präparate
EP0113911B1 (de) Pyrido-triazolochinazoline, ihre Herstellung und Verwendung
DE2727629A1 (de) 1-p-chlorbenzoyl-5-methoxy-2-methyl- 3-indolyl-essigsaeure-2'-phenyl-2'-carbonsaeureaethylester, verfahren zu seiner herstellung und pharmazeutische mittel

Legal Events

Date Code Title Description
PL Patent ceased